Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'

According to a market report by Lucintel, the future of the artificial pancreas device system market looks promising with opportunities in hospitals and medical centers. The global artificial pancreas device system market is expected to grow with a CAGR of 13% to 15% from 2023 to 2028. The major drivers for this market are increasing prevalence of diabetes, rising demand for insulin self administration, and rising demand for automated systems for glycemic control. 

In this market, threshold suspend device systems, control- to-range systems (CTR), and control-to- target systems (CTT) are the major product segments. Lucintel forecasts that threshold suspend device systems will remain the largest segment over the forecast period due to the actions taken automatically when the patient is unable to respond to threshold suspend alarms and stops insulin delivery when the value of sensor glucose reaches a low threshold.

Within this market, hospitals are expected to remain the largest end use industry segment because they contain some of the most efficiently planned referral networks for responding adequately to the population's health needs. 

North America will remain the largest region due to the growing awareness of advanced technologies in diabetes management, high prevalence of obesity, as well as presence of major players in the region, and the presence of efficient reimbursement policies.  

 Medtronic, Bigfoot Biomedical, Johnson & Johnson, Dexcom, Tandem Diabetes Care, Pancreum, TypeZero Technologies, Beta Bionics, and F. Hoffmann-La Roche are the major suppliers in the global artificial pancreas device system market.  

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global artificial pancreas device system market by product, end use industry, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global Artificial Pancreas Device System Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global artificial pancreas device system market by product, end use industry and region, as follows:

 

Artificial Pancreas Device System Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

· Threshold Suspend Device Systems

· Control-to-Range Systems (CTR)

· Control-to-Target Systems (CTT)

Artificial Pancreas Device System Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

· Hospitals

· Medical Centers

· Others

Artificial Pancreas Device System Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

· North America

· Europe

· Asia Pacific

· The Rest of the World


A more than 150 pages and in-depth TOC on “Global Artificial Pancreas Device System Market". To download report brochure, please go to https://www.lucintel.com and click "report brochure" tab from the menu.


For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/artificial-pancreas-device-system-market.aspx or write us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the artificial pancreas device system market by product (threshold suspend device systems, control- to-range systems (CTR), and control-to- target systems (CTT)), end use industry (hospitals, medical centers, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity did occur in the last five years and how did they impact the industry?